Literature DB >> 3138209

Radiation therapy for retinoblastoma: comparison of results with lens-sparing versus lateral beam techniques.

B McCormick1, R Ellsworth, D Abramson, B Haik, M Tome, E Grabowski, T LoSasso.   

Abstract

From 1979 through 1986, 170 children were seen at our institution diagnosed with retinoblastoma. Sixty-six of the children with involvement of 121 eyes, were referred for definitive external beam radiation to one or both eyes. During the study period, two distinct radiation techniques were used. From 1980 through mid-1984, a lens-sparing technique included an anterior electron beam with a contact lens mounted lead shield, combined with a lateral field, was used. Since mid-1984, a modified lateral beam technique has been used, mixing lateral electrons and superior and inferior lateral oblique split beam wedged photons. Doses prescribed were similar for both techniques, ranging from 3,850 to 5,000 cGy in 4 to 5 weeks. The lens-sparing and the modified lateral techniques are compared for local control. For eyes with Group I through III disease, the lens-sparing technique resulted in local control in 33% of the eyes treated, where the modified lateral technique controlled 83% of the eyes treated (p = .006). Mean time to relapse was identical in both groups, that is 24 and 26 months respectively. Most relapses were successfully treated with further local therapy, including laser or cryosurgery, or 60Co plaques. Five eyes required enucleation following initial treatment with the lens-sparing technique, but none thus far with the lateral beam technique. For eyes with Group IV and V disease, no significant differences were found between the two techniques in terms of local control or eventual need for enucleation. With a mean follow-up time of 33 months for the entire group, the 4-year survival is 93%. Two of the 4 deaths are due to second primary tumor, and all 4 have occurred in the lens-sparing group. Because follow-up time is more limited in the lateral beam group, this is not statistically significant and direct survival comparisons are premature.

Entities:  

Mesh:

Year:  1988        PMID: 3138209     DOI: 10.1016/0360-3016(88)90296-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy.

Authors:  Steven M Nguyen; Julian Sison; Marjorie Jones; Jesse L Berry; Jonathan W Kim; A Linn Murphree; Vanessa Salinas; Arthur J Olch; Eric L Chang; Kenneth K Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-12-08       Impact factor: 7.038

2.  Long term follow-up results of external beam radiotherapy as primary treatment for retinoblastoma.

Authors:  Sang Yul Choi; Mi-Sook Kim; Sungyul Yoo; Chulkoo Cho; YoungHoon Ji; KumBae Kim; YoungSeok Seo; Kyung Duk Park; JunAh Lee; Tai-Won Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

Review 3.  Retinoblastoma and vision.

Authors:  Omar Warda; Zishan Naeem; Kelsey A Roelofs; Mandeep S Sagoo; M Ashwin Reddy
Journal:  Eye (Lond)       Date:  2022-01-05       Impact factor: 3.775

4.  External beam radiotherapy for retinoblastoma: II. Lens sparing technique.

Authors:  N M Toma; J L Hungerford; P N Plowman; J E Kingston; D Doughty
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

Review 5.  Current management strategies for intraocular retinoblastoma.

Authors:  Jonathan W Kim; David H Abramson; Ira J Dunkel
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Retinoblastoma: a review.

Authors:  I Malkani; R P Warrier; L C Yu; D L Ode
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

7.  Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.

Authors:  David H Abramson; Brian P Marr; Scott E Brodie; Ira Dunkel; Sotiria Palioura; Y Pierre Gobin
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

8.  Sedation and anesthesia options for pediatric patients in the radiation oncology suite.

Authors:  Eric A Harris
Journal:  Int J Pediatr       Date:  2010-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.